throbber
Adverse reactions
`to sulfites
`
`William H. Yang,"’ MD, FRCPC
`Emerson C.R. Purchase,* MD, FRCPC
`
`Sulfites are widely used as preservatives in the food
`and pharmaceutical industries. In the United States
`more than 250 cases of sulfite-related adverse
`reactions, including anaphylactic shock, asthmatic
`attacks, urticaria and angioedema, nausea, abdomi-
`nal pain and diarrhea, seizures and death, have
`been reported, including 6 deaths allegedly associ-
`ated with restaurant food containing sulfites. In
`Canada 10 sulfite-related adverse reactions have
`been documented, and 1 death suspected to be
`sulfite-related has occurred. The exact mechanism
`
`of sulfite-induced reactions is unknown. Practising
`physicians should be aware of the clinical manifes-
`tations of sulfite-related adverse reactions as well as
`which foods and pharmaceuticals contain sulfites.
`Cases should be reported to health officials and
`proper advice given to the victims to prevent
`further exposure to sulfites. The food industry,
`including beer and wine manufacturers, and the
`pharmaceutical industry should consider using al-
`ternative preservatives. In the interim, they should
`list any sulfites in their products.
`
`On utilise beaucoup les sulfites comme agents de
`conservation dans les
`industries alimentaire et
`pharmaceutique. Aux Etats-Unis on a rapporté plus
`de 250 cas d’effets nuisibles des sulfites, y compris
`choc anaphylactique, asthme, urticaire et oedéme
`géant, nausée, douleurs abdominales et diarrhée,
`convulsions et méme décés; 6 décés seraient reliés 5
`la consommation de sulfite dans un restaurant. Au
`Canada on dénombre 10 cas, dont 1 mortel, ou l’on
`soupconne le r6le d’un sulfite. La pathogénése de
`ces accidents est inconnue. Le praticien doit étre au
`courant de leurs manifestations cliniques et savoir
`quels sont les aliments et les médicaments conte-
`nant des sulfites. On devrait rapporter aux autori-
`tés de santé des cas d’effets nuisibles des sulfites et,
`afin d’éviter l’exposition additionnelle, donner aux
`victimes des conseils adéquats. L’industrie alimen-
`taire, y compris brasseries et établissements oenoco-
`les, et l’industrie pharmaceutique devraient recou-
`
`Immunology,
`From the Section of Allergy and Clinical
`Department of Medicine, Ottawa Civic Hospital and Ottawa
`General Hospital, University of Ottawa
`
`‘Clinical assistant professor, Department of Medicine, Uni-
`versity of Ottawa
`
`Reprint requests to: Dr. William H. Yang, 1081 Carling Ave.,
`Ste. 800, Ottawa, Ont. KIY 4G2
`
`i
`
`la on
`rir 5 d’autres agents de conservation. D’ici
`devrait signaler
`la présence de sulfites sur
`les
`étiquettes.
`
`S ulfites are widely used in food processing to
`
`sanitize fermentation equipment and food
`containers,
`to reduce or prevent microbial
`spoilage of foods, to selectively inhibit undesirable
`microorganisms in fermentation industries and to
`prevent oxidative discolouration and nonenzyme
`browning during preparation, distribution and
`storage of food.” Apparently the earliest known
`use was in the treatment of wines with sulfur
`dioxide in Roman times.‘
`
`Six sulfiting agents have been listed by the
`United States Food and Drug Administration
`(FDA) as generally recognized as safe (GRAS) for
`use in food since 1959:“ sulfur dioxide (S0,),
`sodium sulfite (Na2SO,), sodium and potassium
`bisulfite (NaHSO3 and KHSO3), and sodium and
`potassium metabisulfite (Na2S2O5 and KZSZO5). The
`FDA allows the addition of sulfites to non-thia-
`mine—containing foods and drinks without disclo-
`sure or other restrictions.” Rats maintained on
`diets providing adequate thiamine suffered no ill
`effects attributable to consumption of sulfites, up
`to 300 mg/kg per day.‘ Thiamine—deficient rats,
`however, showed toxic effects at doses as low as 50
`mg/kg per day. Furthermore, although federal and
`state regulations prohibit the use of preservatives
`in ground beef, the addition of sulfites and other
`preservatives to ground beef to preserve the red
`colour has been common practice in the state of
`New York.”
`
`Sulfites are used in restaurant foods to keep
`salad-bar vegetables and fruits looking fresh and
`to prevent browning in avocado dips. They are also
`used in seafood, potatoes, beer, wine, fruit drinks,
`baked goods and dried fruits and in the processing
`of some food ingredients,
`including beet sugar,
`corn sweeteners, food starches and gelatin.3'3-1°!“ In
`addition, many pharmaceuticals contain sulfites as
`antioxidants: they include bronchodilators, such as
`Alupent, Bronkosol, Isuprel, Micronefrin and Va-
`ponefrin;
`injectable Adrenalin;
`local anesthetics,
`such as Novocain and Xylocaine;
`injectable cor-
`ticosteroids,
`including Celestone, Decadron and
`Hydrocortone;
`injectable
`antibiotics,
`including
`Amikin, Garamycin and Nebcin;
`injectable an-
`tiarrhythmics, including Pronestyl; injectable lido-
`caine; analgesics,
`such as Demerol; antishock
`agents, including Aramine, Intropin and Levophed;
`CAN MED ASSOC], VOL. 133, NOVEMBER 1, 1985
`865
`
`SENJU EXHIBIT 2321
`
`Page 1 of 4
`
`SENJU EXHIBIT 2321
`LUPIN v. SENJU
`IPR2015-01105
`
`

`
`ophthalmic drops, including dexamethasone, Pred
`Mild, Pred Forte, prednisolone and sulfacetamide;
`and solutions for total parenteral nutrition and
`dialysis.“*1"
`In Canada manufacturers are required to dis-
`close the presence of sulfiting agents in all manu-
`factured foods and beverages except wine and beer.
`The maximum concentration of sulfiting agents
`allowed in various foods and drinks is shown in
`Table I.
`
`The average person consumes 2 to 3 mg of
`sulfites per day. Wine and beer drinkers consume
`up to 10 mg/d. Restaurant foods may have the
`highest quantity, and those who eat in restaurants
`may ingest up to 150 mg/d.
`
`Clinical manifestations
`
`A level of sulfur dioxide as low as 1 part per
`million (ppm) may provoke airway obstruction in
`subjects with asthma." However, it is reported that
`0.1 to 0.6 ppm of sulfur dioxide may be generated
`during nebulization of bronchodilator solutions
`(e.g., Alupent, Bronkosol, Isuprel and Micronef-
`rin).13 In 1976 Prenner and Stevens” reported the
`first case of anaphylaxis following ingestion of
`sodium metabisulfite in a restaurant salad. Skin
`
`testing and passive transfer testing gave positive
`results, which suggested an IgE-mediated reaction.
`Subsequently it was reported that sulfur dioxide in
`orange drinks could induce asthma attacks.” In
`1977 Stevenson and Simon“ reported on four
`subjects with asthma who were sensitive to meta-
`bisulfites. Using single-blind provocative chal-
`lenge testing with oral gelatin capsules containing
`lactose alone (placebo) or potassium metabisulfite
`in graduated doses of 1, 5, 10, 25 and 50 mg, they
`showed a significant decline in forced expiratory
`volume in 1'second (FEV,) and forced vital capacity
`(FVC) in the subjects. The drop in FEV1 and FVC
`was promptly relieved by an aerosol bronchodila-
`tor. Prick skin testing with potassium metabisul-
`fite gave negative results. There was no peripheral
`basophil histamine release after the addition of
`metabisulfite at concentrations ranging from 10*‘
`M to 10“° M. While these investigators could not
`find evidence of an IgE-mediated reaction,
`they
`postulated that activation of cholinergic reflexes
`could account for the clinical signs and symptoms
`in their four patients.
`Sulfites were subsequently reported to produce
`a wide spectrum of severe adverse reactions, in-
`cluding
`anaphylaxis,1“1
`urticaria
`and
`angio-
`edema,“ asthma,“»2‘-25 abdominal pain and diar-
`rhea,“ seizures“ and death.5'7'27
`
`Incidence
`
`The exact incidence of sulfite sensitivity is not
`known. It has been estimated that 5% to 11% of
`people with asthma may be sensitive to metabisul-
`fites;73‘ thus, approximately 450000 to 990000 of
`the 9 million people with asthma in North Ameri-
`
`866
`
`CAN MED ASSOC _l, VOL. 133, NOVEMBER 1, 1985
`
`ca may be sulfite-sensitive.’ It has recently been
`documented that 30% of the reported cases of
`sulfite sensitivity have been in people with no
`known history of asthma? The exact incidence of
`sulfite sensitivity in the nonasthmatic atopic popu-
`lation and in the general population remains
`virtually unknown; further studies are required to
`explore this.
`The FDA has received more than 250 reports
`of suspected sulfite-related reactions; as of Febru-
`ary 1984 the FDA had received 6 reports of deaths
`allegedly associated with restaurant food contain-
`ing sulfites.” In Canada 10 sulfite-related adverse
`reactions have been reported, and 1 death suspect-
`ed to be sulfite-related has occurred (unpublished
`data, 1985).
`
`Mechanism
`
`n
`
`The exact mechanism of sulfite-induced reac-
`tions remains unknown.” An IgE-mediated mech-
`anism is suggested by the immediate onset of the
`reaction (e.g., anaphylaxis, bronchospasm, urticaria
`and angioedema, and rhinoconjunctivitis) and by
`positive results of scratch and intradermal skin
`testing with sodium bisulfite, 10 mg/mL, and
`passive transfer
`testing.” We reported on four
`patients” (one with anaphylaxis and three with
`asthma) who were found to be sensitive to potassi-
`um metabisulfite in single-blind provocative chal-
`lenge testing according to the protocol of Steven-
`son and Simon.“ Three of
`the four also had
`positive results of skin tests with potassium meta-
`
`Table I-—-Maximum concentration of sulfites allowed in
`various
`foods and drinks in Canada (B.L. Huston:
`personal communication, 1984)
`
`Food or drink
`
`Concentration, parts
`per million tppiri'i*
`
`Fresh or prepared foods and dips in
`salad bars
`Dried fruits and vegetables
`Apple or rhubarb jam, fancy, refiner’s
`or table molasses, fig or pineapple
`marmalade with pectin, frozen sliced
`apples, fruit juices, gelatin, jelly with
`pectin, mincemeat, pickles and
`relishes, tomato paste, tomato puree
`Unstandardized foods'l'
`Beverages
`Frozen mushrooms
`Cider, honey, wine
`Glucose. glucose syrup
`Glucose solids, dried glucose syrup
`Dextrose anhydrous, dextrose
`monohydrate
`Ale, beer, light beer, malt liquor, porter.
`stout
`
`Unlimiteo
`2500
`
`20
`
`15
`
`*1 ppm " 1 mg/kg or 1 mg/L.
`thiamine or
`’FExcept
`those recognized to be a source of
`unstandardized preparations of meat or meat bv~proclucts
`fish, or poultry or poultry by-products.
`iln free state: 350 ppm in combined state as sulfur Cll0XlLl6-'5
`
`Page 2 of 4
`
`

`
`bisulfite, 1 mg/mL (one prick and two intrader-
`mal). Passive transfer testing gave positive results
`in both patients in whom it was carried out.’
`Interestingly, when the serum from these two
`patients was heated to 56°C for 1 hour, passive
`transfer was not demonstrable, which suggested
`that an IgE-mediated mechanism was involved.
`Another possible mechanism is stimulation of
`an orobronchial reflex — possibly due to inhala-
`tion of
`sulfur dioxide during swallowing or
`mouthwashing.”
`More recently Jacobsen and colleagues” dis-
`covered that in sulfite-sensitive subjects with asth-
`ma, sulfite oxidase activity in fibroblasts may be
`reduced.
`Interestingly, cyanocobalamin (vitamin
`B12), 1000 to 5000 ug taken orally, may fully or
`partially block the asthmatic response on challenge
`with metabisulfites.
`
`Conclusions
`
`Practising physicians should be aware of the
`clinical manifestations of sulfite-related adverse
`reactions. Single-blind provocative challenge test-
`ing with oral potassium metabisulfite carried out
`under close supervision by experienced specialists
`is necessary to confirm the diagno5is.“'“'29 Physi-
`cians are urged to report documented sulfite-relat-
`ed adverse reactions to the Food Additives and
`Contaminants Section, Chemical Evaluation Divi-
`sion, Bureau of Chemical Safety, Health Protection
`Branch, Department of National Health and Wel-
`fare, Tunney’s Pasture, Ottawa, Ont. KIA 0L2.
`The ultimate question is, Should sulfites be
`banned? In the United States the National Restau-
`rant Association (NRA) has advised its members,
`who operate 100000 food service outlets, to stop
`using sulfites;"“-1‘ in June 1984 the NRA reported
`that only 4% of its members had continued to use
`sulfites.” The FDA has asked retail food establish-
`ments, including grocery stores and restaurants, to
`inform consumers by signs or notes that sulfiting
`agents have been used. In addition, the FDA has
`advised food processing companies, interstate con-
`veyers and caterers that consumers must be noti-
`fied if sulfites are used on foods that are eaten
`raw."
`safe
`that sulfites are not
`is now clear
`It
`preservatives.“ Consideration should be given to
`using alternatives to sulfiting agents. Agents such
`as 1% to 2% citric acid can prevent browning of
`vegetables such as cauliflower, radishes and pota-
`toes for up to 2 hours at room temperature. For
`long-term protection, 1% citric acid and 0.5% to 1%
`ascorbic acid can extend shelf life up to 7 days.
`One of the advantages of ascorbic acid is that it is
`a nutrient and thus would be favourably viewed by
`the consumer.’ For economic reasons, citric acid
`and erythorbic acid could be used.‘''7 In the interim,
`for consumer protection the food industry, includ-
`ing wine and beer manufacturers, and the pharma-
`ceutical industry should voluntarily list any sul-
`fites in their products.
`
`We are grateful to Dr. Bev Huston, head, Additives and
`Contaminants Section, Chemical Evaluation Division,
`Bureau of Chemical Safety, Health Protection Branch,
`Department of National Health and Welfare, for provid-
`ing the information in Table 1. Our special thanks to
`Drs. Ian Hart, Michel Drouin, Robert Rivington, David
`Copeland and André Peloquin, for their constructive
`criticism and for referring patients, and our office staff,
`for their technical assistance.
`This study was supported by the Dr. Roy Horo-
`vitch Memorial Fund, Department of Medicine, Ottawa
`Civic Hospital.
`
`References
`
`1. Joslyn MA, Braverman JBS: The chemistry and technology
`of the pre-treatment and preservation of fruit and vegetable
`products with sulfur dioxide and sulfites. Adv Food Res
`1954; 5: 97-147
`. Chichester DF, Tanner FW Jr: Sulfur dioxides and sulfites.
`In Furia TE (ed): Handbook of Food Additives, 2nd ed, CRC
`Pr, Cleveland, Ohio, 1972: 142
`. IFT Scientific Status Summary: Sulfites as Food Additives,
`Institute of Food Technologists, Chicago, 1975
`. A scientific status summary by the Institute of Food
`Technologists’ Expert Panel on Food Safety and Nutrition
`and the Committee on Public Information: Sulfites as food
`additives. Nutr Rev 1976; 34: 58-62
`. Hecht A, Willis J: Sulfites: preservatives that can go wrong.
`FDA Consum 1983; Sept: 11
`. Andres C: Sulfites still
`receiving major attention: new
`sulfite alternatives introduced. Food Process 1984; Mar: 34
`. Nolan AL: The sulfite controversy. Food Eng 1983; Oct: 84-
`85, 89-90
`. Code of Federal Regulations, title 21: Food and Drugs (pt
`10-199), Office of the Federal Register, General Services
`Administration, Government Printing Office, Washington,
`1976
`. Karasz AB, Maxstadt JJ, Reher J et al: Preservatives and
`artificial sweeteners — rapid screening procedure for the
`determination of preservatives in ground beef: sulfites,
`benzoates, sorbates, and ascorbates. J Assoc Off Anal Chem
`1976; 59: 766-769
`. Lecos C: Food preservatives: a fresh report. FDA Consum
`1984; Apr: 23-25
`. Levine AS, Labuza TP, Morley JE: Food technology. N Engl
`J Med 1985; 312: 628-634
`. Twarog F], Leung DYM: Anaphylaxis to a component of
`isoetharine (sodium bisulfite). JAMA 1982; 248: 2030-2031
`. Koepke JW, Selner JC, Dunhill AL: Presence of sulfur
`dioxide in commonly used bronchodilator
`solutions. J
`Allergy Clin Imm unol 1983; 72: 504-508
`. Simon RA: Adverse reactions to drug additives. J Allergy
`Clin lmmunol 1984; 74: 623-630
`. Huang AS, Fraser WM: Are sulfite additives really safe? [C].
`N Engl J Med 1984; 311: 542
`. Schwartz HJ, Sher TH: Bisulfite sensitivity manifesting as
`allergy to local dental anesthesia. J Allergy Clin lmmunol
`1985; 75: 525-527
`. Boushey HA: Bronchial hyperreactivity to sulfur dioxide:
`physiologic and political implications. 1 Allergy Clin Im-
`munol 1982; 69: 335-338
`. Koepke JW, Selner JC, Dunhill AL: SO; derived from
`bronchodilator solutions [abstr]. J Allergy Clin lmmunol
`1983; 71: 147
`. Prenner BM, Stevens JJ: Anaphylaxis after ingestion of
`sodium bisulfite. Ann Allergy 1976; 37: 180-182
`. Freedman B]: Asthma induced by sulfur dioxide, benzoate
`and tartrazine contained in orange drinks. Clin Allergy
`1977; 7: 407-415
`
`CAN MED ASSOC J, VOL. 133, NOVEMBER 1, 1985
`
`867
`
`continued on page 880
`
`Page 3 of 4
`
`

`
`to his practice and to his exercise routine over the
`next 6 weeks. Sequelae 15 months later included
`occasional slight loss of balance and low weight.
`
`V Discussion
`
`Torteni noted the absence of a pathognomonic
`syndrome and the presence of misconceptions that
`hinder the diagnosis of leptospirosis in humans‘
`Gutman and coworkers‘ emphasized this problem
`in their account of a patient with leptospirosis that
`was signalled by an ocular disorder. Avery’ and
`Hart and colleagues‘ described the behavioural and
`soclal sconseflllences of .mlsSed !agnoses'
`a.nd
`Cheng specified leptospiral arteritis as a major
`cause of cerebrovascular di5ea5e-
`The use of rapid, accurate methods for detect-
`ing leptospires in blood and urine along with the
`IHA test for early antibodies can facilitate diagno-
`sis. However, the immune response to leptospiral
`infection is highly variable, and, therefore, serolog-
`ic testing alone should not be depelnded upon to
`. establish the diagnosis. Culture of b cod and urine
`samples with commercially available albumin-
`polysorbate-80 medium is now practical and
`should always be done in patients at
`risk of
`leptospirosis. Treatment with doxycycline is indi-
`cated because of its specificity, its ability to pene-
`trate into the cerebrospinal fluid and the anterior
`chamber of the eye, and its long half-life (16 hours)
`in the body.‘
`The potential for exposure of Canadians to
`leptospiral infection increases with the amount of
`time spent with livestock. The risk of this debili-
`tating disease, with its serious sequelae, merits
`much concern: public health authorities should
`obtain survey data, veterinarians should caution
`clients and coworkers and try to control
`the
`sources of infection, and the medical profession
`should recognize leptospirosis as a zoonosis indig-
`enous to Canada.
`
`References
`
`. Torten M: Leptospirosis. ln Steele JH (ed): CRC Handbook
`Series in Zoonosis, vol 1, CRC Pr, Boca Raton, Fla, 1979:
`363-421
`
`. Gutman I, Walsh J B, Knapp AB: Cotton-wool spots as a sign
`in leptospirosis. Ophthalmologica 1983; 187: 133-136
`
`. Avery TL: Leptospirosis and mental illness [C]. NZ Med J
`1983; 96: 701
`
`. Hart RJC, Gallagher I, Waitkins S: An outbreak of lepto-
`spirosis in cattle and men. Br Med J 1984; 288: 1983-1984
`
`. Cheng M-K: A review of cerebrovascular‘ surgery in the
`People's Republic of China. Stroke 1982; 13: 249-255
`
`. McClain JBL, Ballou WR, Harrison SM et al: Doxycycline
`therapy for leptospirosis. Ann Intern Med 1984; 100: 696-698
`
`Addison, pernicious
`continued from page 857
`
`Disease of the Supra—renal Capsules, Samuel Highley,
`London, 1855
`. Garrison F: An Introduction to the History of Medicine, 4th
`ed, Saunders, Philadelphia, 1929: 422-423
`. White IR, MacDonald DM: Thomas Addison, MD. First
`dermatologist at Guy's Hospital. 1 Am Acad Dermatol 1982;
`6: 426_430
`. Long ER: A History of Pathology, Dover, New York, 1965:
`93
`. Upstairs, downstairs at Guy's: Addison, Bright, and Hodg-
`kirk HOSP PMCI1977: 12(5): 119-131
`fif5:;"7!’8‘f";‘9';
`-
`:§4D"5'~’359: 3”‘ ed: CC
`. Hale-White W: Thomas Addison, M.D. Guy's Hosp Rep
`1929;76:253_279
`. Medvei VC: A History of Endocrinology, MTP Pr, Hing-
`ham, Montana, 1982: 225-244
`. Addison T: On the Constitutional and Local Effects of
`Dim‘? 0‘ '1"? 5"P’“°""1 CaP5"1°5r Samuel Hi8h19Yr
`1855‘ 4
`
`lbid: 8
`'
`. Hilton J: Discussion of Dr. Addison's paper on anaemia.
`'
`'
`Med Gazette 1849; 43: 562-563
`. Addison T: On the Constitutional and Local Effects of
`Disease of the Supra-renal Capsules, Samuel Highley,
`London, 1855: 3
`. Wilks 6: Daldy (eds): Prefatory remarks on disease of the
`supra-renal capsules.
`In A Collection of the Published
`Writings of the Late Thomas Addison, M.D., New Syden-
`ham Society, London, 1868
`. Bishop PMF: Dr. Addison and his work. Guy's Hosp Rep
`1955;104:275—294
`.Wilks S, Bettany G: A Biographical History of Guy's
`Hospital, Ward, Lock Bowden, London, 1892: 223-234
`
`Adverse reactions
`continued from page 867
`
`. Stevenson DD, Simon RA: Sensitivity to ingested metabi-
`sulfites in asthmatic subjects. J Allergy Clin lmmunol 1981;
`68: 26-32
`
`. Schwartz H]: Sensitivity to ingested metabisulfite: varia-
`tions in clinical presentation. J Allergy Clin lmmunol 1983;
`71: 487-439
`. Habenicht HA, Preuss L, Lovell RC: Sensitivity to ingested
`metabisulfites: cause of bronchiospasm and urticaria. lm-
`munol Allergy Pract1983; 5: 243
`.Schwartz H], Chester EH: Bronchospastic responses to
`aerosolized metabisulfite in asthmatic subjects: potential
`mechanisms and clinical implications. J Allergy Clin Im-
`munol 1934; 74: 511-513
`. Stevenson DD, Simon RA: Sulfites and asthma [E].
`469-472
`. A growing concern over sulfites. Chem Week 1983; Nov: 16
`. Sulfite update. FDA Drug Bull 1984; 14 (3): 2.4
`. Twarog F] : Metabisulfite sensitivity in asthma. Allergy
`Proc 1983; 4: 100-103
`. Yang WH, Purchase ECR, Rivington RN: Positive Praus—
`nitz—Kiistner reaction in metabisulfite sensitive subjects
`[abstr]. J Allergy Clin lmm unol 1985; 75: 373
`. Delohery J, Castle W, Simmul R et al: Metabisulfite and
`SO; reactivity in asthmatics [abstr]. J Allergy Clin Immunol
`1984; 73: 136
`. Jacobsen DW, Simon RA, Singh M: Sulfite oxidase defi-
`ciency and cobalamin protection in sulfite-sensitive asth-
`matics (SSA) [abstr]. lbid: 135
`
`lbid:
`
`CAN MED ASSOC J, VOL. 133, NOVEMBER 1, 1985
`
`For prescribing information see page 923 —>
`
`Page 4 of 4

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket